Neogene Therapeutics B.V. is located in Amsterdam, Netherlands on Science Park 106. Neogene Therapeutics B.V. is rated 5 out of 5 in the category company in Netherlands. Neogene Therapeutics is a pre-clinical stage biotechnology company aiming to change the paradigm of treatment for solid cancers. Our mission is to provide cancer patients with T cell therapies targeting mutated proteins called neo-antigens, which are present on cancer cells as a consequence of DNA mutations. Neogene is developing novel technologies to enable the engineering of ‘designer T cells’ with neo-antigen specificities that display an optimized ability to seek and destroy cancer cells.
Company size
11-50 employees
Headquarters
Amsterdam, North Holland
Accessibility
Wheelchair-accessible entrance